Ascentage Pharma Group International (FRA:36X)
Germany flag Germany · Delayed Price · Currency is EUR
5.40
+0.10 (1.89%)
Last updated: Jan 23, 2026, 8:55 AM CET

FRA:36X Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1,9081,750900796819896
Market Cap Growth
23.27%94.41%13.02%-2.79%-8.59%28.23%
Enterprise Value
1,9161,831913777702855
Last Close Price
5.005.602.842.962.843.68
PS Ratio
41.1013.4831.7827.99212.05574.86
PB Ratio
23.7548.2399.8714.364.798.45
P/TBV Ratio
28.1580.87-19.595.159.47
EV/Sales Ratio
41.5314.1132.2427.31181.70548.17
Debt / Equity Ratio
2.546.0925.424.390.880.63
Asset Turnover
0.130.380.080.070.010.01
Inventory Turnover
3.702.562.383.29--
Quick Ratio
1.401.171.351.785.053.77
Current Ratio
1.541.261.441.865.223.91
Return on Equity (ROE)
-159.65%-235.32%-386.28%-107.45%-75.18%-78.02%
Return on Assets (ROA)
-22.77%-9.25%-20.92%-19.14%-24.97%-29.14%
Return on Capital Employed (ROCE)
-62.00%-26.10%-57.00%-45.30%-36.20%-47.00%
Earnings Yield
-7.22%-3.07%-13.12%-15.04%-13.22%-9.47%
FCF Yield
-1.35%-1.03%-10.95%-14.60%-17.57%-12.02%
Buyback Yield / Dilution
-12.40%-7.00%-7.07%-3.56%-17.93%-84.97%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.